Gujarat Terce Laboratories Acquisition Worth ₹3.23 Cr
Gujarat Terce Laboratories agreed to buy its corporate office premises 'Swati18' in Ahmedabad. The purchase is for Rs 3.23 Crore, excluding taxes and charges.
- Value
- ₹3.23 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Gujarat Terce Laboratories agreed to buy its corporate office premises 'Swati18' in Ahmedabad. The purchase is for Rs 3.23 Crore, excluding taxes and charges.
Gujarat Terce approved unaudited standalone results for quarter and half year ended September 2026. Q2 profit was 131.92 lakhs against a Q1 loss of 17.81 lakhs.
Gujarat Terce Laboratories will hold a board meeting on November 5, 2026 to consider unaudited standalone results for September 2026. The trading window stays closed until November 7, 2026.
Gujarat Terce Laboratories Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Gujarat Terce Laboratories held its 41st Annual General Meeting on August 21, 2026. Members passed resolutions regarding financial statements and director re-appointments.
Gujarat Terce Laboratories issued a corrigendum clarifying the re-appointment tenure of its MD & CEO, Mr. Aalap Prajapati, as three years instead of five.